Pluribus Labs’s Signify Health, Inc. SGFY Stock Holding History

Pluribus Labs’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,877	Closed	-$155K	–	239
2021 Q4	$155K	Buy	+10,877	New	+$168K	0.16%	222

Other funds holding SGFY

NMVA

New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Grosvenor Holdings Chicago, Illinois $512M AUM 19.57% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Pluribus Labs's SGFY Position: Q1 2022 in Review

Pluribus Labs sold out of Signify Health, Inc. (SGFY) in Q1 2022, closing a stake of 10,877 shares — an estimated $155K sold.

Pluribus Labs first reported a position in SGFY in Q4 2021 and held it in 1 quarter. The position peaked at $155K in Q4 2021. 142 funds tracked by Wall St. Rank hold SGFY as of Q1 2022.

Pluribus Labs reported no remaining Signify Health, Inc. position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 10,877 Signify Health, Inc. shares in Q1 2022, an estimated $155K.
Pluribus Labs first reported a position in Signify Health, Inc. in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Signify Health, Inc. position peaked at $155K in Q4 2021.
142 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.